Literature DB >> 153914

Mechanisms of lymphocyte activation: the role of suppressor cells in the proliferative responses of chronic lymphatic leukemia lymphocytes.

G B Faguet.   

Abstract

Binding of (125)I-leukoagglutinin (LPHA) to lymphocyte membrane receptors at equilibrium generated similar curvilinear Scatchard plots in 20 patients with bursa-derived (B)-cell-type chronic lymphatic leukemia (CLL) and 15 controls. If biphasic plots are assumed, the two linear components show markedly diminished receptor capacity (15 and 137 ng/10(6) lymphocytes) in CLL as compared to controls (60 and 668 ng). In contrast, affinity was similar in patients (1.0 x 10(8) M(-1) and 2.1 x 10(6) M(-1)) and controls (1.8 x 10(8) M(-1) and 1.5 x 10(6) M(-1)). Highly purified B cells from patients and controls generated binding data comparable to that obtained from the mixed lymphocyte (ML) suspensions from which they originated. Maximal DNA synthesis of highly purified, normal, thymus-derived (T) and B cells in response to LPHA stimulation was comparable to that of ML (mitotic index [MI] 19.9, 20.1, and 23.4, respectively), though B-cell responses were slightly delayed. In CLL the markedly decreased and delayed DNA synthesis by ML (MI 2.3), and by highly purified T (MI 1.6) and B (MI 1.9) cells seemed out of proportion to their decreased receptor capacity for LPHA. The impaired mitogenic responses of leukemic cells from five patients were not enhanced when cocultured with normal lymphocytes. In contrast, cells from eight patients inhibited cocultured normal lymphocyte responses to LPHA by 94.3%. Sera from these patients and supernates from their cultured cells did not mediate this suppressor effect. These observations indicate that the decreased DNA synthesis observed in CLL is not an attribute of B cells and does not represent the expected response of a few residual normal T lymphocytes, but rather reflects impaired responses by all CLL cells. The defect does not relate to the density or function of membrane receptors for LPHA, to the presence of inhibitors in these patients' sera, or to depletion of helper T cells. Our data strongly suggest that one mechanism for the immunoincompetence observed in CLL reflects excessive suppressor-cell activity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 153914      PMCID: PMC371919          DOI: 10.1172/JCI109280

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  MLC stimulatory capacity and production of blastogenic factor in patients with chronic lymphatic leukemia and Hodgkin's disease.

Authors:  S Kasakura
Journal:  Blood       Date:  1975-06       Impact factor: 22.113

2.  Clinical staging of chronic lymphocytic leukemia.

Authors:  K R Rai; A Sawitsky; E P Cronkite; A D Chanana; R N Levy; B S Pasternack
Journal:  Blood       Date:  1975-08       Impact factor: 22.113

3.  ALTERATION OF BLOOD GROUP ANTIGENS IN LEUKEMIC LYMPHOCYTES.

Authors:  J I BRODY; L H BEIZER
Journal:  J Clin Invest       Date:  1965-09       Impact factor: 14.808

4.  Further characterization of the circulating cell in chronic lymphocytic leukemia.

Authors:  E F Schultz; S Davis; A D Rubin
Journal:  Blood       Date:  1976-08       Impact factor: 22.113

5.  Interaction of plant lectins with purified human lymphocyte populations: binding characteristics and kinetics of proliferation.

Authors:  D H Boldt; R P MacDermott; E P Jorolan
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

6.  Cellular immunity in sarcoidosis: evidence for an intrinsic defect of effector cell function.

Authors:  G B Faguet
Journal:  Am Rev Respir Dis       Date:  1978-07

7.  Disorders of suppressor immunoregulatory cells in the pathogenesis of immunodeficiency and autoimmunity.

Authors:  T A Waldmann; R M Blaese; S Broder; R S Krakauer
Journal:  Ann Intern Med       Date:  1978-02       Impact factor: 25.391

8.  Quantitation of immunocompetence in Hodgkin's disease.

Authors:  G B Faguet
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

9.  Suppressor cells in tumor-bearing mice capable of nonspecific blocking of in vitro immunization against transplant antigens.

Authors:  A E Eggers; J R Wunderlich
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

View more
  11 in total

1.  Immunogenetic studies in retinoblastoma.

Authors:  D F Roberts; M Duggan-Keen; G E Aherne; D R Long
Journal:  Br J Ophthalmol       Date:  1986-09       Impact factor: 4.638

2.  Binding interaction studies of selected receptor subpopulations after partial cross-linking receptor-ligand complexes with a photoactivated heterobifunctional reagent.

Authors:  G B Faguet; D Beebe
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

3.  The regulation of T cell responses by spontaneously active suppressor cells.

Authors:  J M Dwyer; C Johnson
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

4.  Immunoregulation in hypersensitivity pneumonitis. I. Differences in T-cell and macrophage suppressor activity in symptomatic and asymptomatic pigeon breeders.

Authors:  R H Keller; J N Fink; S Lyman; G Pedersen
Journal:  J Clin Immunol       Date:  1982-01       Impact factor: 8.317

5.  Further evidence for T cell abnormalities in chronic lymphocytic leukaemia of the B cell type.

Authors:  F Herrmann; G Sieber; Z Chen; B Enders; B Komischke; H Rühl
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

Review 6.  The use of concanavalin A to study the immunoregulation of human T cells.

Authors:  J M Dwyer; C Johnson
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

7.  The roles of leukaemic and residual normal cells in the proliferative response of chronic lymphocytic leukaemic lymphocytes to mitogens.

Authors:  A P Johnstone; R E Millard; L Hudson
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

8.  Mitogen-stimulated immunoglobulin production by chronic lymphocytic leukaemic lymphocytes.

Authors:  A P Johnstone; J C Jensenius; R E Millard; L Hudson
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

9.  Influence in vitro on NK and K cell activities by cimetidine and indomethacin with and without simultaneous exposure to interferon.

Authors:  P Flodgren; H O Sjögren
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

10.  Receptors for immunoglobulin isotype on T and B lymphocytes from untreated patients with chronic lymphocytic leukaemia.

Authors:  C D Platsoucas; S Kempin; A Karanas; B Clarkson; R A Good; S Gupta
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.